Longitudinal study of adrenal steroids in a cohort of HIV-infected patients with hemophilia
Longitudinal study of adrenal steroids in a cohort of HIV-infected patients with hemophilia
复制标题
DOI:
10.1016/s0022-2143(96)90145-6
复制
发表时间:
1996-06-01
期刊:
影响因子:
--
通讯作者:
Hechter, O
中科院分区:
文献类型:
--
作者:
Chatterton, RT;Green, D;Hechter, O
The objective of the study was to relate plasma dehydroepiandrosterone sulfate (DHEA-S) concentrations to the progression of HIV infection in individual HIV-infected men with hemophilia and to obtain information on the cause of DHEA-S alterations. Blood samples were obtained from 16 men with hemophilia; in 9 men serial samples were available for up to 11 years after HIV-1 infection. Control samples were obtained from men of comparable ages without hemophilia or HIV infection. Measurements were made of CD4(+) cell counts, plasma adrenocorticotropic hormone (ACTH), cortisol, DHEA, DHEA-S, and prolactin. Before HIV infection, men with hemophilia had significantly lower plasma levels of DHEA-S than control men. After infection, 3 of 9 subjects studied serially had little or no change in plasma DHEA-S levels or in CD4(+) cell counts over 11 years. Four of the 9 in whom AIDS developed had progressive decreases in plasma DHEA-S concentrations that, in some cases, preceded a precipitous fall in CD4(+) cell counts. Major decreases in plasma DHEA-S levels before falls in CD4(+) counts were observed in 2 other subjects who had other severe illnesses. None of the decreases in DHEA-S levels were associated with decreased concentrations of plasma cortisol, ACTH, or prolactin. We conclude that plasma DHEA-S is an indicator of general health rather than a specific indicator for progression of HIV. The decrease in plasma DHEA-S is not related to ACTH stimulation of the adrenal gland or to cortisol secretion, but it may be related to cytokines that can inhibit 17-hydroxylation of DHEA-S precursors.